Retracted: Overexpression of the Insulin Receptor Isoform A Promotes Endometrial Carcinoma Cell Growth (Q34946100)

From Wikidata

Jump to navigation Jump to search

retracted article

Overexpression of the Insulin Receptor Isoform A Promotes Endometrial Carcinoma Cell Growth

Language	Label	Description	Also known as
English	Retracted: Overexpression of the Insulin Receptor Isoform A Promotes Endometrial Carcinoma Cell Growth	retracted article	Overexpression of the Insulin Receptor Isoform A Promotes Endometrial Carcinoma Cell Growth

Statements

scholarly article

1 reference

Europe PubMed Central

5 August 2017

retracted paper

0 references

Overexpression of the insulin receptor isoform A promotes endometrial carcinoma cell growth (English)

1 reference

Europe PubMed Central

5 August 2017

Retracted: Overexpression of the Insulin Receptor Isoform A Promotes Endometrial Carcinoma Cell Growth (English)

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

endometrial carcinoma

1 reference

based on heuristic

inferred from title

author name string

Chun-Fang Wang

1

1 reference

Europe PubMed Central

5 August 2017

Guo Zhang

2

1 reference

Europe PubMed Central

5 August 2017

Li-Jun Zhao

3

1 reference

Europe PubMed Central

5 August 2017

Wen-Juan Qi

4

1 reference

Europe PubMed Central

5 August 2017

Xiao-Ping Li

5

1 reference

Europe PubMed Central

5 August 2017

Jian-Liu Wang

6

1 reference

Europe PubMed Central

5 August 2017

Li-Hui Wei

7

1 reference

Europe PubMed Central

5 August 2017

language of work or name

0 references

publication date

7 August 2013

1 reference

Europe PubMed Central

5 August 2017

1 reference

Europe PubMed Central

5 August 2017

8

1 reference

Europe PubMed Central

5 August 2017

8

1 reference

Europe PubMed Central

5 August 2017

e69001

1 reference

Europe PubMed Central

5 August 2017

copyright license

Creative Commons Attribution 4.0 International

7 August 2013

1 reference

April 2022 Public Data File from Crossref

copyright status

0 references

Will PI3K pathway inhibitors be effective as single agents in patients with cancer?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3737217

8 July 2018

Understanding the mechanism of insulin and insulin-like growth factor (IGF) receptor activation by IGF-II.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3737217

8 July 2018

Common genetic variation within IGFI, IGFII, IGFBP-1, and IGFBP-3 and endometrial cancer risk

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3737217

8 July 2018

Sulfatase 2 protects hepatocellular carcinoma cells against apoptosis induced by the PI3K inhibitor LY294002 and ERK and JNK kinase inhibitors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3737217

8 July 2018

The proliferating role of insulin and insulin-like growth factors in cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3737217

8 July 2018

The expression and role of hybrid insulin/insulin-like growth factor receptor type 1 in endometrial carcinoma cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3737217

8 July 2018

Risk of cancer following hospitalization for type 2 diabetes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3737217

8 July 2018

Insulin receptor functionally enhances multistage tumor progression and conveys intrinsic resistance to IGF-1R targeted therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3737217

8 July 2018

Nongenomic effect of estrogen on the MAPK signaling pathway and calcium influx in endometrial carcinoma cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3737217

8 July 2018

The MEK/ERK cascade: from signaling specificity to diverse functions

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3737217

8 July 2018

Structural determinants for high-affinity binding of insulin-like growth factor II to insulin receptor (IR)-A, the exon 11 minus isoform of the IR.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3737217

8 July 2018

The insulin receptor isoform exon 11- (IR-A) in cancer and other diseases: a review.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3737217

8 July 2018

The phosphoinositide 3-kinase pathway

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3737217

8 July 2018

Insulin receptor isoform A, a newly recognized, high-affinity insulin-like growth factor II receptor in fetal and cancer cells.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3737217

8 July 2018

Tissue-specific expression of two alternatively spliced insulin receptor mRNAs in man.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3737217

8 July 2018

Elevated insulin receptor content in human breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3737217

8 July 2018

Differential endocytosis and signaling dynamics of insulin receptor variants IR-A and IR-B.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0069001

21 January 2018

Functional insulin receptors on human epithelial ovarian carcinoma cells: implications for IGF-II mitogenic signaling

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0069001

21 January 2018

In IGF-I receptor-deficient leiomyosarcoma cells autocrine IGF-II induces cell invasion and protection from apoptosis via the insulin receptor isoform A.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0069001

21 January 2018

Endometrial cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/23950881

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A novel autocrine loop involving IGF-II and the insulin receptor isoform-A stimulates growth of thyroid cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/23950881

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1371/JOURNAL.PONE.0069001

1 reference

Europe PubMed Central

5 August 2017

2013PLoSO...869001W

0 references

1 reference

Europe PubMed Central

5 August 2017

1 reference

Europe PubMed Central

5 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34946100&oldid=1864262901"